Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
tags : Pharma source : Spacfeed.com save search
SPAC throwback: Cormorant launches $100 million blank check co – The Pharma Letter
Published: 2024-01-22 (Crawled : 13:00) - spacfeed.com
PB A | $60.77 1.81% 0.0% 630K
|
Finance
|
| O: 0.57%
H: 1.01%
C: 0.54%
FSR | $0.0896 0.0% 62M
|
Finance
|
| O: 14.34%
H: 23.01%
C: 2.56%
pharma million spac
NewAmsterdam Pharma sets out 2024 strategic priorities – The Pharma Letter
Published: 2024-01-05 (Crawled : 12:00) - spacfeed.com
CPT 4 | $96.29 1.05% 0.0% 650K
|
Finance
|
| O: -0.81%
H: 1.72%
C: 1.21%
pharma
China's Gracell leaps on news of an up to $1.2 billion M&A deal – The Pharma Letter
Published: 2023-12-26 (Crawled : 12:30) - spacfeed.com
RY 1 d | $97.86 0.99% 0.0% 790K
|
Finance
|
| O: 0.2%
H: 0.96%
C: 0.96%
pharma deal
Can AI Help Pharma Overcome Its Formidable Growth Gap – Life Science Leader Magazine
Published: 2023-12-14 (Crawled : 00:00) - spacfeed.com
RCAC | $10.74 0.0% 2.7K
|
n/a
|
| O: -0.09%
H: 0.0%
C: 0.0%
pharma life growth
Citius to spin off oncology division into separate public company – The Pharma Letter
Published: 2023-10-25 (Crawled : 10:00) - spacfeed.com
CPB | $44.2 1.12% 0.0% 2.2M
|
Consumer Non-Durables
|
| O: 0.15%
H: 3.15%
C: 3.13%
pharma company
Pharma Fairytale
Published: 2023-07-18 (Crawled : 14:00) - spacfeed.com
FATP | $10.915 -0.14% 8.2K
|
n/a
|
| O: -0.18%
H: 0.83%
C: 0.28%
pharma
Acquisitions drive growth in pharma and biotech in the first half of 2023 – The Pharma Letter
Published: 2023-07-01 (Crawled : 16:20) - spacfeed.com
USCT | $11.23 0.27% 210
|
n/a
| Email alert
Add to watchlist
pharma acquisitions biotech growth
Aeon Pharma Again Tries the SPAC Route – Orange County Business Journal
Published: 2023-06-30 (Crawled : 18:00) - spacfeed.com
USCT | $11.23 0.27% 210
|
n/a
| Email alert
Add to watchlist
FNCTF | News | $11.0354 -20.84% 320
|
Communications
| Email alert
Add to watchlist
pharma business spac
NewAmsterdam Pharma Announces Closing of Upsized Secondary Offering of Ordinary Shares – Marketscreener.com
Published: 2023-06-09 (Crawled : 21:00) - spacfeed.com
CFFS | $10.84 -0.27% 200
|
n/a
| Email alert
Add to watchlist
VLCN | $0.229 1.1% 1.09% 890K
|
| Email alert
Add to watchlist
pharma offering
NewAmsterdam Pharma Announces Commencement of Secondary Offering of Ordinary Shares – Yahoo Finance
Published: 2023-06-06 (Crawled : 00:00) - spacfeed.com
BBLG | $1.62 -9.75% -10.8% 77K
|
n/a
|
| O: 9.15%
H: 6.33%
C: -16.67%
pharma offering
NewAmsterdam Pharma Announces Positive Topline Results from … – GlobeNewswire
Published: 2023-06-05 (Crawled : 11:00) - spacfeed.com
FWBI | $2.59 -8.8% -9.65% 83K
|
Manufacturing
|
| O: -1.03%
H: 3.11%
C: -11.91%
pharma positive topline results
M&A crackdown a 'disaster' for pharma sector, Pfizer executive warns – Financial Times
Published: 2023-05-17 (Crawled : 20:00) - spacfeed.com
SOFI 4 | $7.12 -0.14% -0.14% 36M
|
Finance and Insurance
|
| O: 0.4%
H: 3.11%
C: 1.81%
pharma financial
NewAmsterdam Pharma Provides Corporate Update and Reports … – Marketscreener.com
Published: 2023-05-08 (Crawled : 13:00) - spacfeed.com
ESAB | $106.02 0.22% 0.0% 190K
|
n/a
|
| O: -0.2%
H: 1.11%
C: -2.81%
BYNO | $11.14 0.09% 0.09% 8.3K
|
n/a
|
| O: 0.24%
H: 0.19%
C: 0.19%
PNAC | $4.26 -46.95% -85.02% 340K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -0.09%
QFTA 4 | $1.56 557.69% 100
|
|
| O: 0.1%
H: 0.0%
C: 0.0%
ATNF | $1.87 2.19% 2.14% 20K
|
|
| O: -0.92%
H: 3.69%
C: 0.0%
pharma update
NewAmsterdam Pharma Provides Corporate Update and Reports … – GlobeNewswire
Published: 2023-05-08 (Crawled : 12:00) - spacfeed.com
ESAB | $106.02 0.22% 0.0% 190K
|
n/a
|
| O: -0.2%
H: 1.11%
C: -2.81%
PNAC | $4.26 -46.95% -85.02% 340K
|
n/a
|
| O: 0.0%
H: 0.0%
C: -0.09%
QFTA 4 | $1.56 557.69% 100
|
|
| O: 0.1%
H: 0.0%
C: 0.0%
pharma update
NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 … – GlobeNewswire
Published: 2023-04-24 (Crawled : 12:20) - spacfeed.com
BRLI | $4.7 31.92% 370K
|
Finance
| Email alert
Add to watchlist
pharma
NewAmsterdam Pharma Completes Enrollment in Pivotal Phase 3 BROOKLYN Clinical Trial Evaluating Obicetrapib in Patients with Heterozygous Familial Hypercholesterolemia – Marketscreener.com
Published: 2023-04-24 (Crawled : 12:20) - spacfeed.com
BRLI | $4.7 31.92% 370K
|
Finance
| Email alert
Add to watchlist
pharma hypercholesterolemia trial
NewAmsterdam Pharma to Present at the SVB Securities Global BioPharma Conference – EIN News
Published: 2023-02-09 (Crawled : 14:00) - spacfeed.com
FST | $10.18 0.2%
|
Finance
| Email alert
Add to watchlist
biopharma pharma global conference
NewAmsterdam Pharma to Present at the SVB Securities Global … – GlobeNewswire
Published: 2023-02-09 (Crawled : 13:20) - spacfeed.com
FST | $10.18 0.2%
|
Finance
| Email alert
Add to watchlist
pharma global
NewAmsterdam Pharma Appoints John W. Smither to its Board of Directors – Yahoo Finance UK
Published: 2023-02-06 (Crawled : 14:00) - spacfeed.com
FST | $10.18 0.2%
|
Finance
| Email alert
Add to watchlist
VSAC | News | $11.13 0.0% 24K
|
n/a
| Email alert
Add to watchlist
pharma
NewAmsterdam Pharma Appoints J – GuruFocus.com
Published: 2023-02-06 (Crawled : 13:20) - spacfeed.com
MCAC | $11.22 0.0% 3
|
Finance
|
| O: 0.0%
H: 0.0%
C: 0.0%
pharma
Gainers vs Losers
| 67% | 33% |
Top 10 Gainers
Your saved searches
Save your searches and get alerts when important news are released.